GlassScriptPhysician profile
Bediola A Badie
NPI 1912907502
$1,658.73
in general payments reported to CMS, 2019-2025
19 companies · $73.02 in 2025
The $73.02 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $850 · 2020: $99.76 · 2021: $167 · 2022: $222 · 2023: $118 · 2024: $130 · 2025: $73.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $461.41 | 2019-2024 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $230.01 | 2019-2024 | Tezspire, Fasenra |
| Alk-Abello, INC | $212.03 | 2019-2023 | Odactra, Grastek, Ragwitek |
| Csl Behring | $185.36 | 2019-2024 | Privigen, Hizentra |
| Genzyme Corporation | $113.81 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $73.62 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $66.97 | 2022-2024 | Cuvitru, Takhzyro |
| Grifols USA, LLC | $43.52 | 2019-2020 | |
| Pfizer INC. | $41.22 | 2020-2023 | |
| Shire North American Group INC | $33.46 | 2019 | |
| Kaleo, INC. | $31.06 | 2019 | |
| Sunovion Pharmaceuticals INC. | $26.91 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $24.69 | 2025 | Neffy |
| Teva Pharmaceuticals USA, INC. | $24.07 | 2021 | |
| Amgen INC. | $22.37 | 2023 | Tezspire |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blueprint Medicines Corporation | $21.75 | 2024 | Ayvakit |
| Octapharma USA, INC. | $18.94 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.44 | 2019 | |
| Organon LLC | $9.09 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bediola Badie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.